Several meta-analyses have indicated that the BIM deletion polymorphism is associated with poor ORR (168–172), consistent with other studies demonstrating that the BIM deletion polymorphism is associated with shorter PFS in patients with NSCLC harboring EGFR mutations who received EGFR-TKIs (168–175). The gene discussed is BCL2L11; the disease is non-small cell lung carcinoma.